As of 2025-09-15, the EV/EBITDA ratio of Intercept Pharmaceuticals Inc (ICPT) is -22.57. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ICPT's latest enterprise value is 915.51 mil USD. ICPT's TTM EBITDA according to its financial statements is -40.56 mil USD. Dividing these 2 quantities gives us the above ICPT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.2x - 14.0x | 10.8x |
| Forward P/E multiples | 10.2x - 16.6x | 12.6x |
| Fair Price | (12.79) - (16.44) | (14.20) |
| Upside | -167.3% - -186.5% | -174.7% |
| Date | EV/EBITDA |